CellaVision AB (publ) (STO:CEVI)
Sweden
· Delayed Price · Currency is SEK 154.40
+1.80 (1.18%)
At close: Mar 9, 2026
CellaVision AB Revenue
CellaVision AB had revenue of 175.63M SEK in the quarter ending September 30, 2025, a decrease of -1.69%. This brings the company's revenue in the last twelve months to 748.45M, up 1.53% year-over-year. In the year 2024, CellaVision AB had annual revenue of 723.22M with 6.78% growth.
Revenue (ttm)
748.45M
Revenue Growth
+1.53%
P/S Ratio
4.86
Revenue / Employee
3.24M
Employees
231
Market Cap
3.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 723.22M | 45.93M | 6.78% |
| Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
| Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
| Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
| Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xvivo Perfusion AB | 812.17M |
| MedCap AB | 2.11B |
| BICO Group AB | 1.50B |
| Paxman AB | 323.56M |
| Vitrolife AB | 3.44B |
| Nolato AB | 9.46B |
| Sedana Medical AB | 200.23M |
| C-Rad AB | 441.90M |
CellaVision AB News
- 4 weeks ago - CellaVision AB (CLVSF) Q4 2025 Earnings Call Highlights: Strong US Growth and New Product ... - GuruFocus
- 4 weeks ago - Q4 2025 CellaVision AB Earnings Call Transcript - GuruFocus
- 5 years ago - 3 Scandinavian Companies With Strong Margin Growth - GuruFocus